Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Hallett David had 26,657 Recursion Pharmaceuticals, Inc. shares withheld for tax (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Hallett David (Chief Scientific Officer) had 26,657 Recursion Pharmaceuticals, Inc. shares withheld for tax at US$3.19 for US$84,903, leaving 1,017,180 shares. Filed Nov 18, 2026 (Form 4).
- Withheld for tax
- 26,657 shares
- Price
- US$3.19
- Value
- US$84,903
- Holding after
- 1,017,180 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Class A Common Stock | Shares withheld for tax | 26,657 | US$3.19 | 1,017,180 | Direct |
Source
Download original · View original at SEC
Related
- Recursion Pharmaceuticals, Inc.
- Hallett David
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Hallett David · Aug 18, 2026
- Form 4 · Hallett David · May 19, 2026
- Form 4 · Taylor Ben R · Nov 18, 2026
- Form 4 · Khan Najat · Nov 18, 2026
- Schedule 13G/A · ARK Investment Management LLC · Nov 13, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026
- Form 4 · Borgeson Blake · Nov 4, 2026